Works by Bakris, George L.

Results: 316
    1
    2

    Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.

    Published in:
    2019
    By:
    • Bakris, George L.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Nowack, Christina;
    • Kolkhof, Peter;
    • Ferreira, Anna C.;
    • Schloemer, Patrick;
    • Filippatos, Gerasimos;
    • Bakris, George L;
    • Anker, Stefan D;
    • Ruilope, Luis M;
    • Ferreira, Anna C;
    • on behalf of the FIDELIO-DKD study investigators;
    • FIDELIO-DKD study investigators
    Publication type:
    journal article
    3
    4
    5
    6

    Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.

    Published in:
    Blood Pressure, 2012, v. 21, n. 2, p. 82, doi. 10.3109/08037051.2011.598699
    By:
    • Kjeldsen, Sverre E.;
    • Jamerson, Kenneth A.;
    • Bakris, George L.;
    • Pitt, Bertram;
    • Dahlöf, Björn;
    • Velazquez, Eric J.;
    • Hua, Tsushung A.;
    • Kelly, Roxzana Y.;
    • Zappe, Dion;
    • Hester, Allen;
    • Tuomilehto, Jaakko;
    • Östergren, Jan;
    • Ibsen, Hans;
    • Weber, Michael
    Publication type:
    Article
    7

    Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: The ACCOMPLISH Study.

    Published in:
    Blood Pressure, 2008, v. 17, n. 1, p. 7, doi. 10.1080/08037050801972857
    By:
    • Kjeldsen, Sverre E.;
    • Jamerson, Kenneth A.;
    • Bakris, George L.;
    • Pitt, Bertram;
    • Dahlöf, Björn;
    • Velazquez, Eric J.;
    • Gupte, Jitendra;
    • Staikos, Linda;
    • Hua, Tsushung A.;
    • Shi, Victor;
    • Hester, Allen;
    • Tuomilehto, Jaakko;
    • Östergren, Jan;
    • Ibsen, Hans;
    • Weber, Michael;
    • for the Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension (ACCOMPLISH) Investigators
    Publication type:
    Article
    8
    9

    Exceptional early blood pressure control rates: The ACCOMPLISH trial.

    Published in:
    Blood Pressure, 2007, v. 16, n. 2, p. 80, doi. 10.1080/08037050701395571
    By:
    • Jamerson, Kenneth;
    • Bakris, George L.;
    • Dahlöf, Björn;
    • Pitt, Bertram;
    • Velazquez, Eric;
    • Gupte, Jitendra;
    • Lefkowitz, Martin;
    • Hester, Allen;
    • Shi, Victor;
    • Kjeldsen, Sverre E.;
    • Cushman, William;
    • Papademetriou, Vasilios;
    • Weber, Michael
    Publication type:
    Article
    10

    Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: A hypertensive population at high cardiovascular risk.

    Published in:
    Blood Pressure, 2007, v. 16, n. 1, p. 13, doi. 10.1080/08037050701217643
    By:
    • Weber, Michael A.;
    • Bakris, George L.;
    • Dahlöf, Björn;
    • Pitt, Bertram;
    • Velazquez, Eric;
    • Gupte, Jitendra;
    • Lefkowitz, Martin;
    • Hester, Allen;
    • Shi, Victor;
    • Weir, Matthew;
    • Kjeldsen, Sverre;
    • Massie, Barry;
    • Nesbitt, Shawna;
    • Ofili, Elizabeth;
    • Jamerson, Kenneth;
    • for the Accomplish Investigators
    Publication type:
    Article
    11
    12
    13
    14

    A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease: The International Verapamil-Trandolapril Study (INVEST): A Randomized Controlled Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2003, v. 290, n. 21, p. 2805, doi. 10.1001/jama.290.21.2805
    By:
    • Pepine, Carl J.;
    • Handberg, Eileen M.;
    • Cooper-DeHoff, Rhonda M.;
    • Marks, Ronald G.;
    • Kowey, Peter;
    • Messerli, Franz H.;
    • Mancia, Giuseppe;
    • Cangiano, José L.;
    • Garcia-Barreto, David;
    • Keltai, Matyas;
    • Erdine, Serap;
    • Bristol, Heather A.;
    • Kolb, H. Robert;
    • Bakris, George L.;
    • Cohen, Jerome D.;
    • Parmley, William W.
    Publication type:
    Article
    15
    16
    17

    Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.

    Published in:
    European Heart Journal, 2012, v. 33, n. 22, p. 2782, doi. 10.1093/eurheartj/ehs257
    By:
    • Zannad, Faiez;
    • Gattis Stough, Wendy;
    • Rossignol, Patrick;
    • Bauersachs, Johann;
    • McMurray, John J.V.;
    • Swedberg, Karl;
    • Struthers, Allan D.;
    • Voors, Adriaan A.;
    • Ruilope, Luis M.;
    • Bakris, George L.;
    • O'Connor, Christopher M.;
    • Gheorghiade, Mihai;
    • Mentz, Robert J.;
    • Cohen-Solal, Alain;
    • Maggioni, Aldo P.;
    • Beygui, Farzin;
    • Filippatos, Gerasimos S.;
    • Massy, Ziad A.;
    • Pathak, Atul;
    • Piña, Ileana L.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24

    Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA<sub>1c</sub> and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897.

    Published in:
    2023
    By:
    • Rossing, Peter;
    • Burgess, Ellen;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Gillard, Pieter;
    • MacIsaac, Richard J.;
    • Wainstein, Julio;
    • Joseph, Amer;
    • Brinker, Meike;
    • Roessig, Lothar;
    • Scott, Charlie;
    • Bakris, George L.;
    • FIDELIO-DKD Investigators;
    • Vallejos, Augusto;
    • MacIsaac, Richard;
    • Schernthaner, Guntram;
    • Canziani, Maria Eugenia F.
    Publication type:
    Correction Notice
    25
    26

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.

    Published in:
    Diabetes Care, 2022, v. 45, n. 12, p. 2991, doi. 10.2337/dc22-0294
    By:
    • Rossing, Peter;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Birkenfeld, Andreas L.;
    • McGill, Janet B.;
    • Rosas, Sylvia E.;
    • Joseph, Amer;
    • Gebel, Martin;
    • Roberts, Luke;
    • Scheerer, Markus F.;
    • Bakris, George L.;
    • Agarwal, Rajiv;
    • AizenbergDiegoBartolacciInésBesadaDiegoBittarJulioChahinMarianoElbertAliciaGelerszteinElizabethLibermanAlbertoMaffeiLauraPérez ManghiFedericoSanabriaHugoVallejosAugustoViñesGloriaWassermannAlfredoAbhayaratnaWalterAcharyaShamasunderEkinciEli;
    • Aizenberg, Diego;
    • Bartolacci, Inés;
    • Besada, Diego;
    • Bittar, Julio;
    • Chahin, Mariano
    Publication type:
    Article
    27

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.

    Published in:
    2022
    By:
    • Rossing, Peter;
    • Burgess, Ellen;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Gillard, Pieter;
    • MacIsaac, Richard J.;
    • Wainstein, Julio;
    • Joseph, Amer;
    • Brinker, Meike;
    • Roessig, Lothar;
    • Scott, Charlie;
    • Bakris, George L.;
    • FIDELIO-DKD Investigators:;
    • Augusto Vallejos (Argentina);
    • Richard MacIsaac (Australia);
    • Guntram Schernthaner (Austria);
    • Pieter Gillard (Belgium)
    Publication type:
    journal article
    28
    29
    30
    31
    32
    33
    34
    35

    Diabetic Kidney Disease: A Report From an ADA Consensus Conference.

    Published in:
    Diabetes Care, 2014, v. 37, n. 10, p. 2864, doi. 10.2337/dc14-1296
    By:
    • Tuttle, Katherine R.;
    • Bakris, George L.;
    • Bilous, Rudolf W.;
    • Chiang, Jane L.;
    • de Boer, Ian H.;
    • Goldstein-Fuchs, Jordi;
    • Hirsch, Irl B.;
    • Kalantar-Zadeh, Kamyar;
    • Narva, Andrew S.;
    • Navaneethan, Sankar D.;
    • Neumiller, Joshua J.;
    • Patel, Uptal D.;
    • Ratner, Robert E.;
    • Connell, Adam T. Whaley;
    • Molitch, Mark E.
    Publication type:
    Article
    36
    37

    Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.

    Published in:
    Nephrology Dialysis Transplantation, 2025, v. 40, n. 2, p. 308, doi. 10.1093/ndt/gfae132
    By:
    • Heerspink, Hiddo J L;
    • Agarwal, Rajiv;
    • Bakris, George L;
    • Cherney, David Z I;
    • Lam, Carolyn S P;
    • Neuen, Brendon L;
    • Sarafidis, Pantelis A;
    • Tuttle, Katherine R;
    • Wanner, Christoph;
    • Brinker, Meike D;
    • Dizayee, Sara;
    • Kolkhof, Peter;
    • Schloemer, Patrick;
    • Vesterinen, Paula;
    • Perkovic, Vlado;
    • investigators, for the FIND-CKD
    Publication type:
    Article
    38

    Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study.

    Published in:
    Nephrology Dialysis Transplantation, 2023, v. 38, n. 2, p. 372, doi. 10.1093/ndt/gfac157
    By:
    • Ruilope, Luis M;
    • Pitt, Bertram;
    • Anker, Stefan D;
    • Rossing, Peter;
    • Kovesdy, Csaba P;
    • Pecoits-Filho, Roberto;
    • Pergola, Pablo;
    • Joseph, Amer;
    • Lage, Andrea;
    • Mentenich, Nicole;
    • Scheerer, Markus F;
    • Bakris, George L
    Publication type:
    Article
    39

    Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.

    Published in:
    Nephrology Dialysis Transplantation, 2022, v. 37, n. 7, p. 1261, doi. 10.1093/ndt/gfab336
    By:
    • Agarwal, Rajiv;
    • Anker, Stefan D;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M;
    • Boletis, John;
    • Toto, Robert;
    • Umpierrez, Guillermo E;
    • Wanner, Christoph;
    • Wada, Takashi;
    • Scott, Charlie;
    • Joseph, Amer;
    • Ogbaa, Ike;
    • Roberts, Luke;
    • Scheerer, Markus F;
    • Bakris, George L
    Publication type:
    Article
    40

    Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.

    Published in:
    Nephrology Dialysis Transplantation, 2013, v. 28, n. 11, p. 2841, doi. 10.1093/ndt/gft445
    By:
    • Lambers Heerspink, Hiddo J.;
    • Chertow, Glenn M.;
    • Akizawa, Tadao;
    • Audhya, Paul;
    • Bakris, George L.;
    • Goldsberry, Angie;
    • Krauth, Melissa;
    • Linde, Peter;
    • McMurray, John J.;
    • Meyer, Colin J.;
    • Parving, Hans-Henrik;
    • Remuzzi, Giuseppe;
    • Christ-Schmidt, Heidi;
    • Toto, Robert D.;
    • Vaziri, Nosratola D.;
    • Wanner, Christoph;
    • Wittes, Janet;
    • Wrolstad, Danielle;
    • de Zeeuw, Dick
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    20. Major Cardiovascular Outcomes in the EXAMINE Trial According to ACE Inhibitor Use (12-OR).

    Published in:
    Nederlands Tijdschrift voor Diabetologie (NTvD), 2015, v. 13, n. 3, p. 75, doi. 10.1007/s12467-015-0041-x
    By:
    • Serné, E.H. (Erik);
    • White, William B.;
    • Wilson, Craig A.;
    • Bakris, George L.;
    • Bergenstal, Richard M.;
    • Cannon, Christopher P.;
    • Cushman, William C.;
    • Fleck, Penny R.;
    • Heller, Simon R.;
    • Kupfer, Stuart;
    • Mehta, Cyrus R.;
    • Menon, Venu;
    • Nissen, Steven E.;
    • Perez, Alfonso T.;
    • Zannad, Faiez
    Publication type:
    Article
    47
    48
    49
    50